G Gopal Sharma π Tutor III β 38.32K Points π Biopharmaceutics and Pharmacokinetic Q. The gold coating on a USP Dissolution apparatus - I basket should be: (A) Not more than 2.5 m in thickness (B) Not more than 0.1 mm in thickness (C) Not more than 0.025 m in thickness (D) Not more than 0.22 mm in thickness ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Not more than 2.5 m in thickness
A Admin π Coach β 38.23K Points π Biopharmaceutics and Pharmacokinetic Q. In vitro dissolution rate studies on drug product are useful in bioavailability evaluation if they are correlated with (A) Disintegration rate (B) In vivo studies in at least 3 species of animals (C) Chemical stability of drugs (D) In vivo studies in human ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) In vivo studies in human
P Priyanka Tomar π Tutor III β 35.28K Points π Biopharmaceutics and Pharmacokinetic Q. USP Apparatus 5 is (A) Flow-through- cell (B) paddle over disk (C) Cylinder (D) Paddle ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) paddle over disk
R Ranjeet π Tutor III β 34.60K Points π Biopharmaceutics and Pharmacokinetic Q. ………………is the ratio of the mean residence time to the absorption time (A) Absorption number (B) Dissolution number (C) Dose number (D) Intrinsic dissolution ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Absorption number
R Ranjeet π Tutor III β 34.60K Points π Biopharmaceutics and Pharmacokinetic Q. According to Biopharmaceutics Classification System (BCS), Class II drugs have (A) High solubility/High permeability (B) Low solubility /High permeability (C) High solubility /Low permeability (D) Low solubility /Low permeability ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Low solubility /High permeability
R Rakesh Kumar π Hard Worker β 28.44K Points π Biopharmaceutics and Pharmacokinetic Q. Which of the following compounds are used as agents to determine Glomerular Filtration Rate? (A) Calcium ion (B) Albumin (C) Creatinine (D) Calcium carbonate ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) Creatinine
S Shiva Ram π Master β 30.44K Points π Biopharmaceutics and Pharmacokinetic Q. What is the driving force for glomerular filtration? (A) Concentration gradient (B) Hydrostatic pressure of plasma (C) High amount of aqueous pores (D) Hydrostatic pressure of blood flow ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) Hydrostatic pressure of blood flow
R Ranjeet π Tutor III β 34.60K Points π Biopharmaceutics and Pharmacokinetic Q. Biotransformation of a medicinal substance results in: (A) Slower urinary excretion (B) Faster urinary excretion (C) Higher binding to membranes (D) Easier distribution in organism ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Faster urinary excretion
G Gopal Sharma π Tutor III β 38.32K Points π Biopharmaceutics and Pharmacokinetic Q. For the calculation of the volume of distribution (Vd) one take into account: (A) Concentration of a substance in urine (B) Concentration of substance in plasma (C) A daily dose of drug (D) Therapeutic width of drug action ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Concentration of substance in plasma
V Vijay Sangwan π Mover β 28.62K Points π Biopharmaceutics and Pharmacokinetic Q. The term "biotransformation" includes the following. (A) Accumulation of substances in a fat tissue (B) Process of physicochemical and biochemical alteration of a drug in the body (C) Binding of substances with plasma proteins (D) Accumulation of substances in a tissue ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Process of physicochemical and biochemical alteration of a drug in the body